Endpoints News 20. Jan. 2026 Teladoc’s mental health arm BetterHelp has quietly expanded the use of AI
Endpoints News 20. Jan. 2026 Exciva raises $59M Series B to fund Phase 2 test of Alzheimer’s agitation drug
Endpoints News 16. Jan. 2026 Agomab and SpyGlass file for IPOs as investor enthusiasm builds after JPM
Endpoints News 16. Jan. 2026 AbbVie, Genmab say Epkinly didn't prolong overall survival in lymphoma study
Endpoints News 16. Jan. 2026 ImmunityBio's cell therapy posts encouraging early data in rare blood cancer
Endpoints News 16. Jan. 2026 European regulators recommended 38 novel drugs in 2025, 15 fewer than the FDA
Endpoints News 16. Jan. 2026 Novo Nordisk, BioMarin make AI moves; Bristol Myers welcomes neurology exec from Eisai
Endpoints News 15. Jan. 2026 New York sues ex-Emergent CEO over insider trading during vaccine manufacturing struggle